<\/p>\n
Eindhoven Venture Capital Fund II (EVCFII) invested in Equflow in 2018 to allow the company to scale up and achieve its intended growth. That was a success. Now Saint-Gobain Life Sciences has announced the acquisition of Equflow.<\/strong><\/p>\n <\/p>\n Equflow is a leading developer and supplier of flow meters, manufactured for a wide variety of commercial and industrial applications. Primarily serving the single use bioprocessing market. The acquisition expands Saint-Gobain’s product capabilities within its Bio-Process Solutions (BPS) business.<\/p>\n <\/p>\n \u201cWe are delighted to welcome Equflow to our organization and are excited about the opportunities this addition creates for our customers,\u201d said Jean Angus, President and CEO of Saint-Gobain Life Sciences. \u201cWhile we see opportunities to leverage Equflow’s fluid metering technologies across all of our businesses, we especially want to expand our single-use capabilities.\u201d With some inherent overlap of customers and geographies, the addition of Equflow’s flowmeters and sensors to Saint-Gobain’s BPS portfolio complements its single-use fluid management solutions.<\/p>\n <\/p>\n “It was important for us to find a partner who understands our applications, customers and markets,” says Dani\u00ebl van Beek, CEO of Equflow BV. \u201cWith Saint-Gobain, we know we have the support and expertise of a global manufacturer, while maintaining our ability to innovate and create custom solutions that meet our customers’ needs.\u201d<\/p>\n <\/p>\n